MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Cardiovascular Systems EPS Ratio 2011-2026 | CSII
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.94 | -0.35 | -0.79 | -0.01 | 0.05 | -0.06 | -1.72 | -1.04 | -1.25 | -1.11 | -0.93 | -0.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.05 | -1.72 | -0.737 |
Quarterly EPS Ratio Cardiovascular Systems
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.2 | -0.27 | -0.47 | -0.25 | -0.23 | -0.22 | -0.45 | -0.15 | - | -0.05 | - | -0.08 | -0.1 | -0.17 | -0.1 | -0.17 | 0.01 | -0.09 | 0.01 | -0.09 | -0.01 | -0.06 | -0.01 | -0.05 | 0.03 | -0.06 | 0.03 | -0.06 | -0.47 | -0.41 | -0.47 | -0.41 | -0.17 | -0.26 | -0.17 | -0.26 | -0.32 | -0.29 | -0.32 | -0.29 | -0.28 | -0.69 | -0.28 | -0.26 | -0.23 | -0.22 | -0.23 | -0.22 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.03 | -0.69 | -0.207 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical devices industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
-0.96 | $ 11.05 | 1.33 % | $ 1.66 B |  USA |
 |
AxoGen
AXGN
|
-0.34 | $ 32.31 | 1.1 % | $ 1.49 B | USA |
 |
Acutus Medical
AFIB
|
-2.81 | - | -26.83 % | $ 2.62 M | USA |
 |
Align Technology
ALGN
|
5.63 | $ 174.33 | 0.68 % | $ 13.1 B | USA |
 |
AdaptHealth Corp.
AHCO
|
-0.52 | $ 12.16 | -0.12 % | $ 1.64 B | USA |
 |
Allied Healthcare Products
AHPI
|
-0.48 | - | 3.58 % | $ 2.21 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-1.28 | - | - | $ 3.31 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-0.13 | $ 0.59 | -3.28 % | $ 36.7 M | USA |
 |
Bio-Rad Laboratories
BIO
|
-25.6 | $ 282.78 | 1.26 % | $ 7.98 B | USA |
 |
BioSig Technologies
BSGM
|
-9.65 | - | 37.08 % | $ 85.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-0.51 | $ 3.32 | 0.61 % | $ 124 M |  France |
 |
Conformis
CFMS
|
-6.99 | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
0.76 | $ 37.99 | 1.06 % | $ 5.66 K | USA |
 |
Boston Scientific Corporation
BSX
|
1.96 | $ 62.08 | 0.52 % | $ 91.9 B | USA |
 |
Apollo Endosurgery
APEN
|
-0.98 | - | - | $ 475 M | USA |
 |
ClearPoint Neuro
CLPT
|
-0.9 | $ 9.12 | 5.01 % | $ 258 M | USA |
 |
Dynatronics Corporation
DYNT
|
-1.43 | - | 14.99 % | $ 929 K | USA |
 |
Helius Medical Technologies
HSDT
|
-14.6 | $ 1.89 | - | $ 1.15 M | USA |
 |
Electromed
ELMD
|
0.89 | $ 24.2 | 0.41 % | $ 205 M | USA |
 |
Avinger
AVGR
|
-23.3 | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
-0.43 | - | -0.97 % | $ 54.4 M | USA |
 |
IRIDEX Corporation
IRIX
|
-0.26 | $ 1.01 | 1.51 % | $ 17.1 M | USA |
 |
Inogen
INGN
|
-0.86 | $ 6.49 | 2.45 % | $ 173 M | USA |
 |
Aziyo Biologics
AZYO
|
1.29 | - | 1.37 % | $ 20.5 M | USA |
 |
GBS
GBS
|
-2 | - | -0.57 % | $ 7.12 M | USA |
 |
LivaNova PLC
LIVN
|
-4.45 | $ 62.57 | -0.33 % | $ 3.41 B |  Britain |
 |
OrthoPediatrics Corp.
KIDS
|
-1.69 | $ 16.5 | 3.32 % | $ 387 M | USA |
 |
LENSAR
LNSR
|
-2.87 | $ 5.83 | 2.28 % | $ 69.7 M | USA |
 |
Globus Medical
GMED
|
3.98 | $ 91.51 | 1.26 % | $ 12.4 B | USA |
 |
Butterfly Network
BFLY
|
-0.34 | $ 4.09 | -0.37 % | $ 866 M | USA |
 |
BIOLASE
BIOL
|
-29.4 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
0.08 | $ 10.18 | 1.34 % | $ 365 M | USA |
 |
Myomo
MYO
|
-0.37 | $ 0.69 | 0.34 % | $ 28.9 M | USA |
 |
Inspire Medical Systems
INSP
|
4.95 | $ 53.79 | -0.39 % | $ 1.58 B | USA |
 |
CONMED Corporation
CNMD
|
1.52 | $ 36.95 | 0.57 % | $ 1.15 B | USA |
 |
NanoVibronix
NAOV
|
-13.7 | - | - | $ 1.08 M | USA |
 |
Integer Holdings Corporation
ITGR
|
2.96 | $ 85.54 | 0.47 % | $ 2.97 B | USA |
 |
FONAR Corporation
FONR
|
1.78 | $ 18.66 | -0.11 % | $ 122 M | USA |